Screener
NeoGenomics NEO EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from NeoGenomics’s reported figures.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
FAQ
- What is NeoGenomics's EBIT?
- NeoGenomics (NEO) reported EBIT of -$9.77M in Q2 2026.
- How has NeoGenomics's EBIT changed year-over-year?
- NeoGenomics's EBIT increased by 79.5% year-over-year, from -$47.63M to -$9.77M.
- What is the long-term trend for NeoGenomics's EBIT?
- Over 4 years (2021 to 2025), NeoGenomics's EBIT has grown at a -0.6% compound annual growth rate (CAGR), from -$118.75M to -$115.88M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about NeoGenomics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude